Skip to main content

Table 1 Primer sets for determination of perforin CpG methylation by pyrosequencing

From: Determination of quantitative and site-specific DNA methylation of perforinby pyrosequencing

Amplicon*

(bp)

PCR primers (5' to 3')

Sequencing primers

CpG site # and nucleotide

position

A (236)

FW: TTG ATT TTA TAG GTG AGG AAA TTA

RV: TTC CAA CTA TCA CCC ATA ACC TAA

TTT TAT AGG TGA GGA AAT TA

A Y GTTTAGAAAGGGGGTTGATATTTAT Y GT Y GTGAGGTATA Y GG

ATT TTT ATG TTT TTT AAA T

Y GGTTTTTTTGTTA

1, -1365; 2, -1339; 3, -1336; 4, -1325

6, -1231

B (226)

FW: ATG TTG AGG TTG TGA GGA GTT TT

RV: AAA TTC CAA AAT CCT CTC TTT AAT

GAA GTT TTG TAA AGT ATT TG

Y GGGAAAAGAG

5, -1267

C (196)

FW: TTG GAA AGT GAT TAG GAG GTT GTA

RV: CAA ACT CCA AAC CAC ATA TAA CAT

AGA GGG TGG GGA TATT

G Y GGAGAGAAGATGGGGTTAGATTT Y G

GTT TTT GTT TTT GTA AGA GT

AGGGA Y GGAAGTAGGGATATAAA Y G

7, -1110; 8, -1088

9, -1045; 10, -1027

D (91)

FW: GAG GTT TTT ATG GGT GGA GTG AT

RV:CAC CTC CTC CCT TAC CCA ACT A

TTG GGG GGT AAA ATT

ATA Y GGTTTT T

11, -876

E (256)

FW: TTT TGA GTG GGA GAA GAG AGA TGT

RV:CCC CAC CCT AAC CTC AAA CA

GTG AGA GTG GTT TGG TAG

TAT Y GGAGG

TTG GTT TTA GTT TTG TTG A

GGT Y GTGGGT

AGG ATA GTT AGT GGT TTT TA

Y GTTGGTTTTAGTTTTGTTG

12, -776

13, -774

14, -720

F (167)

FW: TGG AGG TTA TTG GTT GTT TTT ATA

RV: TAA CCA TTC CCT CCT CCC TAA ATA

GGT TAT TGG TTG TTT TTA TA

AAG Y GAGGAG T AGGAGTTTTTGTT Y GAGGAATATGTTTGGAGTT Y GG

15, -691; 16, -670; 17, -650

G (300)

FW: TTA GGG AGG AGG GAA TGG TTA TAG

RV: AAC CAA CAA AAC CAT CTC CTT ACT

TAG TTT ATA TTG TTG GTG TA

TAAT Y GAGTTGTTTAAGTTT Y GG Y GGTTTGG Y G

18, -397; 19, -381; 20, -378; 21, -370

H (300)

FW: TTT AGG GAG GAG GGA ATG GTT ATA

RV: ACC AAC AAA ACC ATC TCC TTA CTT

TAC TTC TAA TAC ACA ACA TC

R CATATATAAAATATAAAAAACAAACAAAAAC R AC R AC

24, -313; 23, -345; 22, -348

I (233)

FW: GGG GAT TTA GGG TAT ATA GG

RV: AAA CCC TAC CAA TCC ACA CTA CT

GGG GAT TTA GGG TAT AT

AGG Y GGAGGAGGG Y GGGG Y GTTGAGGATTTTGAGATT Y GGT

28, -219; 27, -229; 26, -234; 25, -253

J (237)

FW: TGG TTT TGT TGG TTT GTT TAT TAA

RV: CCC CAA CTA TAA TCA CAA ATC CTT

CAA AAC CAA AAA CTC ATC T

ACC R AATAAAACTACTAAAACTC R

CCT CAA CCC TCA TCC

R ACTCCCCACTAACAACCCTCAAAAAAC R AAC

30, -180; 29, -200

32, -122; 31, -150

K (97)

FW: TTG AGG ATA GGG TGG GTG TT

RV: CCA CCA CTC ACA TCA CTT CTA CTT

GGA TAG GGT GGG TGT T

Y GTGGGAGGGGAGAGTATAAAGGATTTGTGATTATAGTTGGGGG Y

33, -92; 34, -48

  1. *Nucleotide positions of amplicons from 5' → 3' direction of the top or bottom strand used for assay design. A, 20 – 255; B, 1186 – 1411; C, 250 – 445; D, 826 – 916; E, 569 – 824; F, 692 – 858; G, 838 – 1137; H, 837 – 1136; I, 200 – 432; J, 1124 – 1360; K, 1298 – 1394. Amplicons in bold (B, D, E and I) represent those amplicons designed using the bottom strand after bisulfite conversion.
  2. Fw, forward primer; Rv, reverse primer. Biotinylated primers are indicated in bold.
  3. Sequencing primers are indicated in bold. Sequences to analyze are italicized with the CpG sites (Y or R) underlined.
  4. Indicates CpG site number and corresponding nucleotide location from the distal end of the promoter. Numbering is based on the top strand used for assay design.